Matches in Nanopublications for { ?s ?p "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_provenance.
- NP650838.RArfCjUpiWSAXEIkaRS7yKn1uQjbeRHrw05EiRr-_iT4o130_assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650838.RArfCjUpiWSAXEIkaRS7yKn1uQjbeRHrw05EiRr-_iT4o130_provenance.
- NP673393.RAhCWrcOUDsJsG0HUKu1ht-K9kB_dZa_DPPNRCm5K6Aig130_assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673393.RAhCWrcOUDsJsG0HUKu1ht-K9kB_dZa_DPPNRCm5K6Aig130_provenance.
- assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_provenance.
- NP451202.RAutNZahqZUch00xne5ZewZEwOmCGqEN7-HWkF5vmWdT4130_assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451202.RAutNZahqZUch00xne5ZewZEwOmCGqEN7-HWkF5vmWdT4130_provenance.
- NP480732.RAMzJr-NxkBovpQ0sj0hAGHfLhz_bOjl6v-LFYFUuQ2fY130_assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480732.RAMzJr-NxkBovpQ0sj0hAGHfLhz_bOjl6v-LFYFUuQ2fY130_provenance.
- NP480735.RA9SJ82515HyN9m6-v2cKmgjHtXaGpxcQEL5R22_B4Xys130_assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480735.RA9SJ82515HyN9m6-v2cKmgjHtXaGpxcQEL5R22_B4Xys130_provenance.